|
2020-10-14 |
2020-10-10 |
A
Achat
|
IONIS PHARMACEUTICALS INC
Actionnaire important
|
21 237 715
+27.6%
18,15
385 464 527 USD
|
21 237 715
+27.6%
|
18,15
|
385 464 527 USD
|
|
|
2020-09-24 |
2020-09-22 |
V
Vente
|
McDevitt Damien
Chief Executive Officer
Administrateur exécutif
|
8 709
-3.5%
18,12
157 807 USD
|
8 709
-3.5%
|
18,12
|
157 807 USD
|
|
|
2020-09-24 |
2020-09-22 |
V
Vente
|
Jenne Kyle
Chief Commercial Officer
Dirigeant
|
720
-1.4%
18,12
13 046 USD
|
720
-1.4%
|
18,12
|
13 046 USD
|
|
|
2020-09-24 |
2020-09-22 |
V
Vente
|
Patterson Joshua F.
General Counsel
Dirigeant
|
319
-1.2%
18,12
5 780 USD
|
319
-1.2%
|
18,12
|
5 780 USD
|
|
|
2020-07-20 |
2020-07-17 |
V
Vente
|
Patterson Joshua F.
General Counsel
Dirigeant
|
263
-1.0%
12,50
3 288 USD
|
263
-1.0%
|
12,50
|
3 288 USD
|
|
|
2020-03-25 |
2020-03-23 |
V
Vente
|
Patterson Joshua F.
General Counsel
Dirigeant
|
335
-2.2%
11,76
3 938 USD
|
335
-2.2%
|
11,76
|
3 938 USD
|
|
|
2020-03-25 |
2020-03-23 |
V
Vente
|
O'Dea Louis
Chief Medical Officer
Dirigeant
|
3 198
-4.9%
11,75
37 579 USD
|
3 198
-4.9%
|
11,75
|
37 579 USD
|
|
|
2020-03-25 |
2020-03-23 |
V
Vente
|
McDevitt Damien
Chief Executive Officer
Administrateur exécutif
|
9 417
-3.7%
11,75
110 649 USD
|
9 417
-3.7%
|
11,75
|
110 649 USD
|
|
|
2020-03-25 |
2020-03-23 |
V
Vente
|
Jenne Kyle
Chief Commercial Officer
Dirigeant
|
779
-1.5%
11,75
9 153 USD
|
779
-1.5%
|
11,75
|
9 153 USD
|
|
|
2019-07-17 |
2019-07-15 |
V
Vente
|
Boyce Sarah
President
Administrateur exécutif
|
1 819
-8.4%
23,52
42 783 USD
|
1 819
-8.4%
|
23,52
|
42 783 USD
|
|
|
2019-04-09 |
2019-04-08 |
VP
Vente planifiée
|
Soteropoulos Paula
Chief Executive Officer
Administrateur exécutif
|
1 787
-100.0%
32,17
57 480 USD
|
1 787
-100.0%
|
32,17
|
57 480 USD
|
|
|
2019-04-09 |
2019-04-08 |
VP
Vente planifiée
|
Goldberg Jeff Marc
Chief Operating Officer
|
20 000
-87.4%
31,72
634 418 USD
|
20 000
-87.4%
|
31,72
|
634 418 USD
|
|
|
2019-04-09 |
2019-04-05 |
VP
Vente planifiée
|
Soteropoulos Paula
Chief Executive Officer
Administrateur exécutif
|
30 000
-100.0%
32,11
963 300 USD
|
30 000
-100.0%
|
32,11
|
963 300 USD
|
|
|
2019-04-09 |
2019-04-05 |
VP
Vente planifiée
|
Goldberg Jeff Marc
Chief Operating Officer
|
30 000
-91.2%
31,71
951 300 USD
|
30 000
-91.2%
|
31,71
|
951 300 USD
|
|
|
2019-03-07 |
2019-03-06 |
VP
Vente planifiée
|
Soteropoulos Paula
Chief Executive Officer
Administrateur exécutif
|
18 386
-100.0%
32,14
590 856 USD
|
18 386
-100.0%
|
32,14
|
590 856 USD
|
|
|
2018-04-19 |
2018-04-17 |
A
Achat
|
IONIS PHARMACEUTICALS INC
Actionnaire important
|
10 666 666
+20.0%
18,75
199 999 988 USD
|
10 666 666
+20.0%
|
18,75
|
199 999 988 USD
|
|
|
2017-07-21 |
2017-07-19 |
A
Achat
|
IONIS PHARMACEUTICALS INC
Actionnaire important
|
3 125 000
+7.4%
8,00
25 000 000 USD
|
3 125 000
+7.4%
|
8,00
|
25 000 000 USD
|
|
